ORLANDO, Fla.--(BUSINESS WIRE)--RainDance Technologies, Inc. today announced the commercial availability of the HLASeq™ Research Screening Panel, a comprehensive genetic screening solution for human leukocyte antigen (HLA) and major histocompatibility complex (MHC) research using next-generation sequencing technology. The announcement was made at the annual American Association for Cancer Research (AACR) meeting in Orlando, Florida.
